Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? NO

2011 ◽  
Vol 22 (6) ◽  
pp. 576-581 ◽  
Author(s):  
Massimo Marignani ◽  
Marco Canzoni ◽  
Raffaele D'Amelio ◽  
Emanuela De Santis ◽  
Alessandra Pecchioli ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document